Astralis has begun Phase I clinical trial for Psoraxine for the treatment of moderate plaque psoriasis.
25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Indoor Tanning and Melanoma
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement
Annual Meeting Session Highlights Clinical Pearls in Medical Dermatology